SCHEMBL4249094

SCHEMBL4249094

Nc1c(C(=O)O)cccc1-c1ccccc1Cl

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.57
TSHR P16473 1/20 0.53
G6PD P11413 1/20 0.52
CASP7 P55210 1/20 0.52
CASP6 P55212 1/20 0.52
MYC P01106 1/20 0.47
HAVCR2 Q8TDQ0 1/20 0.46
MEN1 O00255 3/20 0.46
KMT2A Q03164 3/20 0.46
LMNA P02545 2/20 0.46
POLB P06746 2/20 0.46
MAPT P10636 2/20 0.46
RECQL P46063 2/20 0.46
THRB P10828 1/20 0.46
MAPK1 P28482 1/20 0.46
PBRM1 Q86U86 1/20 0.45
ALOX15 P16050 1/20 0.45
MAPK14 Q16539 2/20 0.44
HNF4A P41235 1/20 0.44
ALPL P05186 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30462475 0.88 TSHR (0.61) ALDH1A1TSHRG6PDCASP7CASP6
SCHEMBL17744802 0.87 G6PD (0.61) ALDH1A1G6PDCASP7CASP6MYC
SCHEMBL9851131 0.87 G6PD (0.65) ALDH1A1TSHRG6PDCASP7CASP6
SCHEMBL30593461 0.85 KMT2A (0.51) ALDH1A1TSHRG6PDCASP7CASP6
SCHEMBL2930892 0.83 ALDH1A1 (0.68) ALDH1A1TSHRMYCMEN1KMT2A
SCHEMBL146560 0.83 TSHR (0.63) ALDH1A1TSHRG6PDCASP7CASP6
SCHEMBL6316176 0.81 G6PD (0.55) ALDH1A1G6PDCASP7CASP6MYC
SCHEMBL28724984 0.81 ALDH1A1 (0.61) ALDH1A1TSHRMYCMEN1KMT2A
SCHEMBL30462493 0.81 NOTUM (0.47) ALDH1A1TSHRG6PDCASP7CASP6
SCHEMBL30462473 0.81 TSHR (0.45) ALDH1A1TSHRG6PDCASP7CASP6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090131527-A1 NOVEL ANTHRANILIC ACID DERIVATIVES AND CHLORIDE CHANNEL BLOCKING AGENT CONTAINING THE SAME KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) 2009-05-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090131527-A1 NOVEL ANTHRANILIC ACID DERIVATIVES AND CHLORIDE CHANNEL BLOCKING AGENT CONTAINING THE SAME CLIC1, ASIC1, CLIC4 ALDH1A1 1179/4885TSHR 3762/4885G6PD 2031/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.